Brought to you by 
ConvaTec completes £1.5bn IPO on LSE
27 Oct 2016
Executive Summary
ConvaTec Inc. (devices, accessories, and supplies for the hospital market to treat and manage chronic conditions) grossed approximately £1.47bn ($1.8bn) in its initial public offering on the London Stock Exchange. The company issued new shares at a price of £2.25 (the low end of its anticipated range) to certain institutional and other investors in the UK and outside the US. Following the close of the IPO, Nordic Capital and Avista Capital Partners will respectively hold 45.1% and 19.5% ownership stakes. ConvaTec will use most of the proceeds to repay existing debt.
Deal Industry
- Medical Devices
- Services
-
Medical Devices
- Consumables, Central Supplies
- Infusion Therapy Equipment and Supplies
- Monitoring Equipment & Devices
- Rehabilitation Equipment and Devices
- Surgical Equipment & Devices
Deal Status
- Final
Deal Type
-
Financing
- IPO
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
ConvaTec completes £1.5bn IPO on LSE
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice